key: cord-0785377-34wfrkjm
authors: Lee, Yena; Yang, Bing Xiang; Liu, Qian; Luo, Dan; Kang, Lijun; Yang, Fang; Ma, Simeng; Lu, Weicong; Chen‐Li, David; Rosenblat, Joshua D.; Mansur, Rodrigo B.; Nasri, Flora; Subramaniapillai, Mehala; Liu, Zhongchun; McIntyre, Roger S.; Lin, Kangguang
title: Synergistic effect of social media use and psychological distress on depression in China during the COVID‐19 epidemic
date: 2020-07-29
journal: Psychiatry Clin Neurosci
DOI: 10.1111/pcn.13101
sha: 31314a86764b4f6f95c94e3ff64763c029d8fc2f
doc_id: 785377
cord_uid: 34wfrkjm

nan

loneliness attributable to frequent and prolonged social media (SM) use outside the context of epidemics, frequent exposure to fearful and exaggerated information through SM can exacerbate psychological and emotional distress. 2, 3 We investigated the impact of SM use and psychological and emotional distress on depression in 3064 adults in Mainland China. A national convenience sample of 2574 health-care workers and 490 non-medical workers in China was surveyed cross-sectionally by telephone or WeChat between 29 January and 11 February 2020. Our study participants consisted of physicians (n = 783), nurses (n = 1587), and other medical staff (n = 204) employed in health-care settings providing direct care for patients in hospitals, as well as 490 adults not employed in a health-care setting ( We analyzed PHQ-9 score as a continuous outcome variable using generalized linear models with a negative binomial distribution and as a dichotomous outcome variable using binomial logistic regression models (reported in Supplementary Information) . We evaluated the synergistic effect of prolonged SM use to obtain information about COVID-19 and psychological and emotional distress as a result of the epidemic on the risk for depression in Mainland China. We evaluated whether the odds of depressive symptoms with more prolonged SM use and greater psychological and emotional distress were significantly greater than the sum of the odds of depressive symptoms with more prolonged SM use alone and with greater distress alone. We calculated a synergy index and relative excess risk due to interaction to model interaction effects, with adjustments for age, sex, educational attainment, marital status, living arrangements, and healthcare/non-health-care-worker status separately for each IES-R subscale. 4,5. The mean (standard error) PHQ-9 score among study participants was 5.2 (0.1), denoting the presence of clinically significant depressive symptoms. Approximately 18.1% (n = 554) of all participants reported spending less than 1 h per day on an SM platform in the past week, 41.6% (n = 1306) reported spending 1-2 h per day, 22.5% (n = 689) reported spending 3-4 h per day, and 16.8% (n = 515) reported spending more than 5 h per day on an SM platform. Greater time spent on SM predicted greater depressive symptom severity (Fig. S1 ). IES-R Intrusion and Hyperarousal subscale scores significantly predicted PHQ-9 scores, while the Avoidance subscale scores did not (Table S1) .

Individuals reporting both prolonged SM use (i.e. ≥3 h per day) and significant symptoms of distress, particularly hyperarousal, had significantly higher odds of having depressive symptoms or probable depression relative to individuals with either factor alone (Fig. 1) . That is, the odds of depression with prolonged SM use and significant hyperarousal symptoms were significantly greater than the sum of the odds of depression with prolonged SM use (in the absence of significant hyperarousal) and hyperarousal (with reduced SM use), as instantiated by a positive synergistic effect (Table S2) .

SM networks can be used to provide reassurance, increase public awareness about effective ways to reduce risk of infection, and communicate practical information to curb public panic and reduce the mental health burden of public health crises. 6 However, SM use is also associated with elevated risk for depression: greater symptoms of depression and loneliness are observed in young adults who use SM extensively. 7, 8 Moreover, during public health crises, SM can aggravate public fear and panic: for example, SM networks have been implicated in the spread of false information and amplification of risk and harm during the 2014 Ebola outbreak. 9 There is an urgent and unmet need to address the impact of COVID-19 on the mental health of affected individuals.

Data are available on request from the authors.

Additional Supporting Information may be found in the online version of this article at the publisher's web-site:

Appendix S1 Supplementary information.

Mean 9-item Patient Health Questionnaire (PHQ-9) scores are significantly higher among individuals with more prolonged social media use. Marginal means reported after adjustment for age, sex, educational attainment, marital status, living arrangement, and health-care/non-healthcare-worker status.

Demographics and summary of model effects on depressive symptom severity (according to the 9-item Patient Health Questionnaire [PHQ-9] total score as a continuous variable). 

The global economic burden of noncommunicable diseases. Program on the Global Demography of Aging

Fear on the networks: Analyzing the 2014 Ebola outbreak

Mass media and the contagion of fear: The case of Ebola in America

Estimating measures of interaction on an additive scale for preventive exposures

Calculating measures of biological interaction

The pandemic of social media panic travels faster than the COVID-19 outbreak

No more FOMO: Limiting social media decreases loneliness and depression

Smartphones, social media use and youth mental health

Spreading Ebola panic: Newspaper and social media coverage of the 2014 Ebola health crisis

We would like to thank the participants from Wuhan and across Mainland China for their generosity with their time and completing the survey. We would like to thank the medical staff who work directly with patients infected with SARS-Cov-2 for their courage and commitment during this difficult period. This work was supported by the National Key R&D Program of China (2018YFC1314600 to Dr Z. Liu).

R.S.M. has received research grant support from the Stanley Medical Research Institute, CIHR/GACD/Chinese National Natural Research Foundation; speaker/consultation fees from Lundbeck, Janssen, Shire, Purdue, Pfizer, Otsuka, Allergan, Takeda, Neurocrine, Sunovion, and Minerva. All other authors declare no competing interests.